Q4 2023 Marksans Pharma Ltd Earnings Call Transcript
Ladies and gentlemen, good day and welcome to the Marksans Pharma Q4 FY23 earnings conference call hosted by Ambit Capital. (Operators Instruction). Please note that this conference call is being recorded. I now hand the conference over to Mr. Prashant Nair from Ambit Capital. Thank you and over to you, sir.
Thank you, Ryan. Good afternoon, everyone, and thank you for dialling in. I am Prashant Nair, healthcare analyst at Ambit Capital. I would like to thank the Marksans Pharma management for giving us the opportunity to host this call.
From the company today, we have with us Mr. Mark Saldanha, Founder, Chairman and Managing Director and Mr. Jitendra Sharma, Chief Financial Officer. I will now hand over the call to Mark for opening remarks and to take it forward. Over to you, Mark.
Thank you, Prashant. Welcome, everyone, and thank you for joining us in our Q4 FY23 and FY23 earning conference call. We appreciate your
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
